We have expanded our product line with 17 new chemical precursors for radiopharmaceutical production.
🔹 New FAP-targeted ligands — including FAPI-46, NOTA-FAPI-46, and HYNIC-FAPI-4 — for advanced PET and SPECT imaging of FAP-positive tumors.
🔹 New PSMA tracers like HYNIC-PSMA, and PSMA-BCH for prostate cancer diagnostics and therapy.
🔹 Expanded somatostatin ligand range with NOTA-based analogues: NOTA-TATE, NOTA-TOC, and NOTA-NOC.
🔹 New section: PET tracer chemical precursors for ¹⁸F and ¹¹C labelling, including [¹⁸F]FET and [¹¹C]L-methionine synthesis.
🔹 New FAP-targeted ligands — including FAPI-46, NOTA-FAPI-46, and HYNIC-FAPI-4 — for advanced PET and SPECT imaging of FAP-positive tumors.
🔹 New PSMA tracers like HYNIC-PSMA, and PSMA-BCH for prostate cancer diagnostics and therapy.
🔹 Expanded somatostatin ligand range with NOTA-based analogues: NOTA-TATE, NOTA-TOC, and NOTA-NOC.
🔹 New section: PET tracer chemical precursors for ¹⁸F and ¹¹C labelling, including [¹⁸F]FET and [¹¹C]L-methionine synthesis.
All products are:
✔ GMP-compliant
✔ Sterility and endotoxin tested
✔ Supplied ready-to-label for clinical or research use
👉 Browse the updated catalog now: link